0 items USD 0.00Search
- Did you mean
- everbilt
Your search for "everolimus" gave back 118 results.
Afinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures. The global...
颁补迟补濒辞驳:听
MRRPB5
January 2024
Price: USD 2,900.00
The global Everolimus API market was valued at US$ 645 million in 2022 and is anticipated to reach US$ 878 million by 2029, witnessing a CAGR of 4.3...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Everolimus Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
Everolimus is also known as afinator or zortress, afinator is a cancer medicine that inhibits growth of cancer cells and reduces progression of...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
Renal cell carcinoma is the most common type of kidney cancer in adults. It accounts for approximately 3% of adult malignancies and 90-95% of...
颁补迟补濒辞驳:听
iGATE
May 2016
Price: USD 1,190.00
The global Pancreatic Cancer Treatment Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of...
颁补迟补濒辞驳:听
MRRPB5
October 2023
Price: USD 2,900.00
The global Neuroendocrine Tumor Treatment market size was valued at USD 1538.6 million in 2023 and is forecast to a readjusted size of USD 2260...
颁补迟补濒辞驳:听
GIR
July 2024
Price: USD 3,480.00
The global Pancreatic Cancer Treatment Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a...
颁补迟补濒辞驳:听
MRRPB5
February 2024
Price: USD 2,900.00
The global Pancreatic Cancer Treatment Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Pancreatic...
颁补迟补濒辞驳:听
LPI
September 2024
Price: USD 3,660.00
The global market for Pancreatic Cancer Treatment Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$...
颁补迟补濒辞驳:听
MRRPB5
September 2024
Price: USD 3,950.00
The global Kidney Cancer and Renal Cell Carcinoma (RCC) Drugs market size was valued at USD 5255.3 million in 2023 and is forecast to a readjusted...
颁补迟补濒辞驳:听
GIR
July 2024
Price: USD 3,480.00
The global Drug Coated Stent market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of...
颁补迟补濒辞驳:听
GIR
September 2024
Price: USD 3,480.00
Global Anaplastic Thyroid Cancer Drugs market is accounted for $ 139.56 million in 2017 and is expected to reach $ 231.81 million by 2026 growing at...
颁补迟补濒辞驳:听
Stratistics MRC
June 2019
Price: USD 4,150.00
The global Neuroendocrine Tumor Treatment market size was valued at US$ 1462.8 million in 2023. With growing demand in downstream market, the...
颁补迟补濒辞驳:听
LPI
March 2024
Price: USD 3,660.00
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-...
颁补迟补濒辞驳:听
MRRPB5
November 2023
Price: USD 2,900.00
听
